Serial 98199739
Live / Registered — Registered (as of 29 Jul 2025)
What this means for you
Registered since 29 Jul 2025. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 29 Jul 2031: the §8 declaration of use).
Record
- Serial number
- 98199739
- Registration number
- 7874907
- Mark type
- Design / logo
- Filed
- 27 Sept 2023
- Published for opposition
- 02 Jul 2024
- Registered
- 29 Jul 2025
- Next maintenance filing
- §8 declaration of use, due by 29 Jul 2031 (grace period to 29 Jan 2032)
- Attorney of record
- John L. DuPre'
Goods and services
- Class 005 — Pharmaceuticals: pharmaceutical products and preparations for the treatment of anemia; pharmaceuticals for the treatment of anemia
Owner
- Akebia Therapeutics, Inc., Waltham, MA, US
- Akebia Therapeutics, Inc., Cambridge, MA, US
- Akebia Therapeutics, Inc., Cambridge, MA, US
Prosecution history
- 14 Sept 2026 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 14 Sept 2026 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 14 Sept 2026 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 14 Sept 2026 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 14 Sept 2026 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 17 Sept 2025 — ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
- 29 Jul 2025 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 29 Jul 2025 — REGISTERED-PRINCIPAL REGISTER
- 16 Jul 2025 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 08 Jul 2025 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 18 Jun 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 18 Jun 2025 — STATEMENT OF USE PROCESSING COMPLETE
- 06 Jan 2025 — USE AMENDMENT FILED
- 18 Jun 2025 — SOU EXTENSION 1 GRANTED
- 24 Feb 2025 — SOU EXTENSION 1 FILED